Vraylar 3 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F6DBV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,083
Award facts
- Contract value 100% obligated
- $35,082.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order valued at $35,082.90 by the Defense Logistics Agency (DLA) on December 16, 2025, for the supply of Vraylar 3 mg capsules (30-count units). The contract is classified as firm fixed price with no set-aside designation, indicating competitive award. Performance will be completed by December 17, 2025, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
The delivery order is part of AmerisourceBergen's comprehensive pharmaceutical supply relationship with the DLA Medical Supply Chain, which supports military and veteran healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen supplies a broad portfolio of medications across multiple therapeutic domains, including neurological treatments such as Vraylar, which is indicated for psychiatric conditions. The DLA's Pharmaceutical Prime Vendor Global Program Generation V initiative is expected to award multiple contracts across separate regions, positioning AmerisourceBergen as a critical vendor supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems with flexible and reliable pharmaceutical procurement capabilities.
Quick answers
Who was awarded contract SPE2DR26F6DBV?
SPE2DR26F6DBV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26F6DBV worth?
The government has obligated $35,083 on SPE2DR26F6DBV.
Is contract SPE2DR26F6DBV an order under another contract?
Yes. SPE2DR26F6DBV is a delivery order under SPE2DR25D2213, an indefinite delivery contract.
Was contract SPE2DR26F6DBV competed?
The extent of competition for SPE2DR26F6DBV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award